Khiron Life Sciences (KHRNF) Stock Price, News & Analysis

Company Overview

Khiron Life Sciences Corp. was a Canadian medical cannabis company focused on developing, producing and distributing cannabis-based products for patients and healthcare professionals. Its business included medical cannabis formulations, patient education and related healthcare services, with an emphasis on regulated international markets rather than the Canadian adult-use cannabis market.

The company developed the Zerenia medical cannabis clinic platform, which was designed to provide physician consultations, patient monitoring and access to prescribed cannabis treatments. Khiron also marketed medical cannabis products under brands including Kuida and operated through a combination of cultivation, manufacturing, distribution and clinic activities.

Khiron’s operations historically focused on Latin America and Europe, particularly Colombia, Peru, Brazil and the United Kingdom. The company was founded in 2012, and Alvaro Torres served as its co-founder and chief executive officer. Khiron later experienced significant financial and operational challenges, including creditor-protection proceedings in Canada, and publicly available information about its ongoing operations is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 168,014 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:KHRNF
• CIK: N/A
• Web: www.khiron.ca
• Phone: (702) 527-3564
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A